Laboratory diagnosis of Buruli ulcer disease

Future Microbiology

Volumn 5, Issue 3, 2010, Pages 363-370

  Beissner, Marcus ^a   Herbinger, Karl Heinz ^a   Bretzel, Gisela ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Buruli ulcer; Culture; Histopathology; IS2404 PCR; Laboratory confirmation; Microscopy

Indexed keywords

BACTERIAL DNA;

BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BURULI ULCER; CULTURE MEDIUM; DIAGNOSTIC ACCURACY; DNA EXTRACTION; DNA PURIFICATION; HISTOPATHOLOGY; HUMAN; LABORATORY DIAGNOSIS; MICROSCOPY; MYCOBACTERIUM ULCERANS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SMEAR;

BACTERIOLOGICAL TECHNIQUES; BURULI ULCER; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; DRUG MONITORING; HISTOCYTOCHEMISTRY; HUMANS; MICROSCOPY; MYCOBACTERIUM ULCERANS; POLYMERASE CHAIN REACTION;

BACILLI (CLASS); MYCOBACTERIUM ULCERANS;

EID: 77949403340     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.10.3     Document Type: Review

References (52)

1. WHO: Buruli ulcer: progress report 2004-2008. Wkly Epidemiol. Rec. 17, 145-154 (2008).
2. Junghanss T, Um Boock A, Vogel M, Schütte D, Weinlaeder H, Pluschke G: Phase change material for thermotherapy of Buruli ulcer: a prospective observational single centre proof-of-principle trial. PLoS Negl. Trop. Dis. 3(2), E380 (2009).
3. Ellen DE, Stienstra Y, Teelken MA, Dijkstra PU, Van Der Graaf W T, Van Der Werf TS: Assessment of functional limitations caused by Mycobacterium ulcerans infection: towards a Buruli ulcer functional limitation score. Trop. Med. Int. Health 8(1), 90-96 (2003).
4. Phanzu DM, Bafende EA, Dunda BK et al.: Mycobacterium ulcerans disease (Buruli ulcer) in a rural hospital in Bas-Congo, Democratic Republic of Congo, 2002-2004. Am. J. Trop. Med. Hyg. 75(2), 311-314 (2006).
5. WHO: Buruli Ulcer: prevention of disability (POD). Manual for health care providers. WHO, Geneva, Switzerland (2006).
6. Schunk M, Thompson W, Klutse E et al.: Outcome of patients with Buruli ulcer after surgical treatment with or without antimycobacterial treatment in Ghana. Am. J. Trop. Med. Hyg. 81(1), 75-81 (2009).
7. WHO: Provisional guidance on the role of specifc antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer). Manual for health care providers. WHO, Geneva, Switzerland (2004).
8. WHO: Diagnosis of Mycobacterium ulcerans disease. Manual for health care providers. WHO, Geneva, Switzerland (2001).
9. Herbinger KH, Adjei O, Awua-Boateng NY et al.: Comparative study of the sensitivity of different diagnostic methods for the laboratory diagnosis of Buruli ulcer disease. Clin. Infect. Dis. 48(8), 1055-1064 (2009).
10. Bretzel G, Siegmund V, Nitschke J et al.: A stepwise approach to the laboratory diagnosis of Buruli ulcer disease. Trop. Med. Int. Health 12(1), 89-96 (2007).
11. Siegmund V, Adjei O, Nitschke J et al.: Dry reagent-based polymerase chain reaction compared with other laboratory methods available for the diagnosis of Buruli ulcer disease. Clin. Infect. Dis. 45(1), 68-75 (2007).
12. Mensah-Quainoo E, Yeboah-Manu D, Asebi C et al.: Diagnosis of Mycobacterium ulcerans infection (Buruli ulcer) at a treatment centre in Ghana: a retrospective ana lysis of laboratory results of clinically diagnosed cases. Trop. Med. Int. Health 13(2), 191-198 (2008)
13. WHO: Meeting of the WHO technical advisory group on Buruli ulcer. 3 April, 2008. WHO, Geneva, Switzerland (2008).
14. Affolabi D, Tanimomo-Kledjo B, Anyo G, Johnson RC, Anagonou SY, Portaels F: Setting up a national reference laboratory for Buruli ulcer: the case of Benin. Trop. Med. Int. Health 13(3), 365-368 (2008).
15. Affolabi D, Bankole H, Ablordey A et al.: Effects of grinding surgical tissue specimens and smear staining methods on Buruli ulcer microscopic diagnosis. Trop. Med. Int. Health 13(2), 187-190 (2008).
16. Eddyani M, Debacker M, Martin A et al.: Primary culture of Mycobacterium ulcerans from human tissue specimens after storage in semisolid transport medium. J. Clin. Microbiol. 46(1), 69-72 (2008).
17. Yeboah-Manu D, Bodmer T, Mensah-Quainoo E, Owusu S, Ofori-Adjei D, Pluschke G: Evaluation of decontamination methods and growth media for primary isolation of Mycobacterium ulcerans from surgical specimens. J. Clin. Microbiol. 42(12), 5875-5876 (2004).
18. Palomino JC, Portaels F: Effects of decontamination methods and culture conditions on viability of Mycobacterium ulcerans in the Bactec system. J. Clin. Microbiol. 36(2), 402-408 (1998).
19. Palomino JC, Obiang AM, Realini L, Meyers WM, Portaels F: Effect of oxygen on growth of Mycobacterium ulcerans in the Bactec system. J. Clin. Microbiol. 36(11), 3420-3422 (1998).
20. Talaat AM, Reimschuessel R, Trucksis M: Identifcation of mycobacteria infecting fsh to the species level using polymerase chain reaction and restriction enzyme ana lysis. Vet. Microbiol. 58(2-4), 229-237 (1997).
21. Kim BJ, Lee SH, Lyu MA et al.: Identifcation of mycobacterial species by comparative sequence ana lysis of the RNA polymerase gene (rpoB). J. Clin. Microbiol. 37(6), 1714-1720 (1999).
22. Roth A, Reischl U, Streubel A et al.: Novel diagnostic algorithm for identifcation of mycobacteria using genus-specifc amplifcation of the 16S-23S rRNA gene spacer and restriction endonucleases. J. Clin. Microbiol. 38(3), 1094-1104 (2000).
23. Kim H, Kim SH, Shim TS et al.: PCR restriction fragment length polymorphism ana lysis (PRA)-algorithm targeting 644 bp heat shock protein 65 (hsp65) gene for differentiation of Mycobacterium spp. J. Microbiol. Methods 62(2), 199-209 (2005).
24. Guarner J, Bartlett J, Whitney EA et al.: Histopathologic features of Mycobacterium ulcerans infection. Emerg. Infect. Dis. 9(6), 651-656 (2003).
25. Schütte D, Um-Boock A, Mensah-Quainoo E, Itin P, Schmid P, Pluschke G: Development of highly organized lymphoid structures in Buruli ulcer lesions after treatment with rifampicin and streptomycin. PLoS Negl. Trop. Dis. 1(1), E2 (2007).
26. Siegmund V, Adjei O, Racz P et al.: Dry-reagent-based PCR as a novel tool for laboratory confrmation of clinically diagnosed Mycobacterium ulcerans-associated disease in areas in the tropics where M. ulcerans is endemic. J. Clin. Microbiol. 43(1), 271-276 (2005).
27. Johnson PD, Hayman JA, Quek TY et al.: Consensus recommendations for the diagnosis, treatment and control of Mycobacterium ulcerans infection (Bairnsdale or Buruli ulcer) in Victoria, Australia. Med. J. Aust. 186(2), 64-68 (2007).
28. Phillips R, Horsfeld C, Kuijper S et al.: Sensitivity of PCR targeting the IS2404 insertion sequence of Mycobacterium ulcerans in an assay using punch biopsy specimens for diagnosis of Buruli ulcer. J. Clin. Microbiol. 43(8), 3650-3656 (2005).
29. Phillips RO, Sarfo FS, Osei-Sarpong F et al.: Sensitivity of PCR targeting Mycobacterium ulcerans by use of fne-needle aspirates for diagnosis of Buruli ulcer. J. Clin. Microbiol. 47(4), 924-926 (2009).
30. Saxegaard F: Isolation of Mycobacterium paratuberculosis from intestinal mucosa and mesenteric lymph nodes of goats by use of selective Dubos medium. J. Clin. Microbiol. 22(2), 312-313 (1985).
31. Portaels F, Agular J, Fissette K et al.: Direct detection and identifcation of Mycobacterium ulcerans in clinical specimens by PCR and oligonucleotide-specifc capture plate hybridization. J. Clin. Microbiol. 35(5), 1097-1100 (1997).
32. Guimaraes-Peres A, Portaels F, De Rijk P et al.: Comparison of two PCRs for detection of Mycobacterium ulcerans. J. Clin. Microbiol. 37(1), 206-208 (1999).
33. Stienstra Y, Van Der Werf TS, Guarner J et al.: Analysis of an IS2404-based nested PCR for diagnosis of Buruli ulcer disease in regions of Ghana where the disease is endemic. J. Clin. Microbiol. 41(2), 794-797 (2003).
34. Eddyani M, Fraga AG, Schmitt F et al.: Fine needle aspiration, an effcient sampling technique for the bacteriological diagnosis of nonulcerative Buruli ulcer lesions. J. Clin. Microbiol. 47(6), 1700-1704 (2009).
35. Rondini S, Horsfeld C, Mensah-Quainoo E, Junghanss T, Lucas S, Pluschke G: Contiguous spread of Mycobacterium ulcerans in Buruli ulcer lesions analysed by histopathology and real-time PCR quantifcation of mycobacterial DNA. J. Pathol. 208(1), 119-128 (2006).
36. Ross BC, Marino L, Oppedisano F, Edwards R, Robins-Browne RM, Johnson PD: Development of a PCR assay for rapid diagnosis of Mycobacterium ulcerans infection. J. Clin. Microbiol. 35(7), 1696-1700 (1997).
37. Durnez L, Stragier P, Roebben K, Ablordey A, Leirs H, Portaels F: A comparison of DNA extraction procedures for the detection of Mycobacterium ulcerans, the causative agent of Buruli ulcer, in clinical and environmental specimens. J. Microbiol. Methods 76(2), 152-158 (2009).
38. Roberts B, Hirst R: Immunomagnetic separation and PCR for detection of Mycobacterium ulcerans. J. Clin. Microbiol. 35(10), 2709-2711 (1997).
39. Stinear T, Ross BC, Davies JK et al.: Identifcation and characterization of IS2404 and IS2606: two distinct repeated sequences for detection of Mycobacterium ulcerans by PCR. J. Clin. Microbiol. 37(4), 1018-1023 (1999).
40. Sizaire V, Nackers F, Comte E, Portaels F: Mycobacterium ulcerans infection: control, diagnosis, and treatment. Lancet Infect. Dis. 6(5), 288-296 (2006).
41. Rondini S, Mensah-Quainoo E, Troll H, Bodmer T, Pluschke G: Development and application of real-time PCR assay for quantifcation of Mycobacterium ulcerans DNA. J. Clin. Microbiol. 41(9), 4231-4237 (2003).
42. Fyfe JA, Lavender CJ, Johnson PD et al.: Development and application of two multiplex real-time PCR assays for the detection of Mycobacterium ulcerans in clinical and environmental samples. Appl. Environ. Microbiol. 73(15), 4733-4740 (2007).
43. Noeske J, Kuaban C, Rondini S et al.: Buruli ulcer disease in Cameroon rediscovered. Am. J. Trop. Med. Hyg. 70(5), 520-526 (2004).
44. Hellyer TJ, Desjardin LE, Teixeira L, Perkins MD, Cave MD, Eisenach KD: Detection of viable Mycobacterium tuberculosis by reverse transcriptase-strand displacement amplifcation of mRNA. J. Clin. Microbiol. 37(3), 518-523 (1999).
45. Desjardin LE, Perkins MD, Wolski K et al.: Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy. Am. J. Respir. Crit. Care Med. 160(1), 203-210 (1999).
46. Phetsuksiri B, Rudeeaneksin J, Supapkul P, Wachapong S, Mahotarn K, Brennan PJ: A simplifed reverse transcriptase PCR for rapid detection of Mycobacterium leprae in skin specimens. FEMS Immunol. Med. Microbiol. 48(3), 319-328 (2006).
47. Martinez AN, Lahiri R, Pittman TL et al.: Molecular determination of Mycobacterium leprae viability using real-time PCR. J. Clin. Microbiol. 47(7), 2124-2130 (2009).
48. Roth A, Fischer M, Hamid ME, Michalke S, Ludwig W, Mauch H: Differentiation of phylogenetically related slowly growing mycobacteria based on 16S-23S rRNA gene internal transcribed spacer sequences. J. Clin. Microbiol. 36(1), 139-147 (1998).
49. Park H, Jang H, Song E et al.: Detection and genotyping of mycobacterium species from clinical isolates and specimens by oligonucleotide array. J. Clin. Microbiol. 43(4), 1782-1788 (2005).
50. Kim BJ, Lee KH, Park BN et al.: Differentiation of mycobacterial species by PCR-restriction ana lysis of DNA (342 base pairs) of the RNA polymerase gene (rpoB). J. Clin. Microbiol. 39(6), 2102-2109 (2001).
51. Martin A, Uwizeye C, Fissette K et al.: Application of the hsp65 PRA method for the rapid identifcation of mycobacteria isolated from clinical samples in Belgium. J. Microbiol. Methods 71(1), 39-43 (2007).
52. Leão SC, Sampaio JLM, Martin A, Palomino JP, Portaels F: Profling Mycobacterium ulcerans with hsp65. Emerg. Infect. Dis. 11(11), 1795-1796 (2005).